loader image

Pipeline

First-in-class oncology programmes

  • Discovery
  • Preclinical
  • Phase 1
  • Phase 2
  • Phase 3

MAPK Pathway

  • 18% 18%

Synthetic Lethality

In Partnership with:
  • 18% 18%

First-in-class Gram-negative antibacterial programmes

  • Discovery
  • Preclinical
  • Phase 1
  • Phase 2
  • Phase 3

OPT-200 LPS Inhibitor

  • 20% 20%

OPT-500 Isoprenoid Biosynthesis

In Partnership with:
  • 18% 18%

OPT-600 Isoprenoid Biosynthesis

In Partnership with:
  • 18% 18%

Whole cell dynamic computational model of E. coli

Most advanced model of its kind currently covering >3000 genes.

We have used systems biology and Machine learning to build a detailed dynamic model of E.coli.

The model is utilised to discover new biology and identify viable drug targets.

Pin It on Pinterest